| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |